Results 41 to 50 of about 7,879 (209)

Hypereosinophilia–An Unusual Cause of Multiple Embolic Strokes and Multi-Organ Dysfunction [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
‘Eosinophilia’ can occur due to a large number of allergic, infectious, neoplastic, and idiopathic diseases. It can range in severity from a self-limiting condition to a life-threatening disorder. The term ‘hypereosinophilia’ refers to eosinophil levels
Geeta A. Khwaja   +7 more
doaj   +1 more source

Recalcitrant course of bullous pemphigoid indicating coexisting hypereosinophilic syndrome: A case report and literature review

open access: yesClinical Case Reports, 2023
Key Clinical Message As dermatologists, we must be aware that even limited localized lesions may signal a life‐threatening condition, for which early diagnosis and treatment can improve the prognosis. Abstract Bullous pemphigoid is an autoimmune disorder
Raziyeh Ganji   +3 more
doaj   +1 more source

Eosinophilia characterized by a rare CCT6B mutation and responsive to tyrosine kinase inhibition: Case report and literature review

open access: yesLeukemia Research Reports, 2021
Hypereosinophilic syndrome is a rare disorder arising from neoplastic, or idiopathic causes. The availability of NGS panels has increasingly identified rare mutations as underlying pathogenic events and have led to reclassification of cases of idiopathic
Abhay Singh   +4 more
doaj   +1 more source

Hypereosinophilic Syndrome Simulating an Acute Coronary Syndrome [PDF]

open access: yes, 2015
Objectives: to report a case of hypereosinophilic syndrome which presented clinically acute coronary syndrome. Materials and methods: we describe a case of a 69-year-old woman with acute coronary syndrome and peripheral hypereosinophilia.
Neves, Clarinda   +9 more
core   +1 more source

Acute kidney injury secondary to thrombotic microangiopathy associated with idiopathic hypereosinophilic syndrome: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2019
Background Renal involvement in idiopathic hypereosinophilic syndrome is uncommon. The mechanism of kidney damage can be explained as occurring via two distinct pathways: (1) thromboembolic ischemic changes secondary to endocardial disruption mediated by
Diana Curras-Martin   +9 more
doaj   +1 more source

Watershed Infarctions and Hypereosinophilic Syndrome Secondary to Metastatic Lung Cancer: A Case Report [PDF]

open access: yes, 2021
Watershed infarcts are traditionally attributed to ischemia caused by hypoperfusion, with or without vessel stenosis. Implicated diseases usually include atherosclerosis, congestive heart failure, hypotension, angiitis, and less commonly ...
Tsui, Brian Q   +3 more
core   +1 more source

Idiopathic Hypereosinophilic Syndrome Presenting With Acute Heart Failure and Mesenteric Thromboembolism: Review of the Literature*

open access: yes, 2018
Acute heart failure due to cardiac involvement of idiopathic hypereosinophilic syndrome has poor prognosis and high mortality rate. We present a 52 year old male patient with hypereosinophilic syndrome resulting in acute heart failure and mesenteric ...
Demet Menekșe Gerede   +5 more
core   +1 more source

Hypereosinophilia causes progressive cardiac pathologies in mice

open access: yesiScience, 2023
Summary: Hypereosinophilic syndrome is a progressive disease with extensive eosinophilia that results in organ damage. Cardiac pathologies are the main reason for its high mortality rate.
Nicola Laura Diny   +11 more
doaj   +1 more source

Hypereosinophilic Syndrome: Contemporary Approaches to Molecular-Genetic Diagnostics and Gene-Engineered Biologic Therapy

open access: yesМедицина и биотехнологии
Introduction. In recent years, there has been a growing interest among researchers in conditions associated with hypereosinophilia and the therapeutic potential of genetically engineered biological agents.
Larisa A. Balykova   +4 more
doaj   +1 more source

Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma

open access: yesRespiratory Research
Conventional immunosuppressants are ineffective for the management of EGPA-related asthma. Tezepelumab is a human monoclonal antibody that inhibits thymic stromal lymphopoietin (TLSP) that has proven efficacy in several phase 3 studies for the treatment ...
Nina Vincent-Galtié   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy